MDS: Refining existing therapy through improved biologic insights.
Blood Rev
; 26(2): 73-80, 2012 Mar.
Article
in En
| MEDLINE
| ID: mdl-22137600
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Myelodysplastic Syndromes
/
Antineoplastic Agents
Type of study:
Prognostic_studies
Aspects:
Patient_preference
Limits:
Humans
Country/Region as subject:
America do norte
Language:
En
Journal:
Blood Rev
Journal subject:
HEMATOLOGIA
Year:
2012
Document type:
Article
Affiliation country:
United States
Country of publication:
United kingdom